Literature DB >> 3276539

Maintenance of normal rat mammary epithelial cells by insulin and insulin-like growth factor 1.

S Deeks1, J Richards, S Nandi.   

Abstract

Normal rat mammary epithelial cells were cultured within a rat tail collagen gel matrix formed under improved conditions for controlling pH and osmolarity. Under these conditions, growth can be maintained for up to 3 weeks with a 10- to 15-fold increase in cell number. The cells grow in response to prolactin, progesterone, epidermal growth factor, and cholera toxin, in a medium of DME: Ham's F12 supplemented with BSA and insulin at 10 micrograms/ml. When the insulin concentration was reduced to more physiological levels (10 ng/ml) the cells did not grow. However, at these more physiological concentrations it could be shown that insulin had a concentration-dependent effect on the maintenance of the cells with an optimum concentration around 25 ng/ml. The cells could be maintained in hormone-supplemented medium with low levels of insulin in a quiescent state for up to 14 days. The high levels of insulin needed for optimal growth could be replaced by insulin-like growth factor 1 (IGF-1) at much lower concentrations (25-50 ng/ml). The superphysiological level of insulin required for optimum growth is probably due to its acting weakly through an IGF-1-mediated growth-promoting mechanism. Insulin's effect on cell maintenance occurs at physiological levels and may better reflect its role in mammary cell growth.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3276539     DOI: 10.1016/0014-4827(88)90314-x

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  13 in total

Review 1.  Control of milk secretion and apoptosis during mammary involution.

Authors:  C J Wilde; C H Knight; D J Flint
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

2.  Effects of antioxidants and reduced oxygen tension on rat mammary epithelial cells in culture.

Authors:  T P Lin; Y K Hom; J Richards; S Nandi
Journal:  In Vitro Cell Dev Biol       Date:  1991-03

3.  Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice.

Authors:  S Visonneau; A Cesano; M H Torosian; E J Miller; D Santoli
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

4.  Primary culture of normal rat mammary epithelial cells within a basement membrane matrix. I. Regulation of proliferation by hormones and growth factors.

Authors:  H A Hahm; M M Ip
Journal:  In Vitro Cell Dev Biol       Date:  1990-08

Review 5.  The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands.

Authors:  T L Wood; M M Richert; M A Stull; M A Allar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-01       Impact factor: 2.673

6.  Cultured proliferating rat mammary epithelial cells.

Authors:  U K Ehmann; R C Osborn; R C Guzman; L F Fajardo
Journal:  In Vitro Cell Dev Biol       Date:  1991-09

Review 7.  Interactions of prolactin and growth hormone (GH) in the regulation of mammary gland function and epithelial cell survival.

Authors:  D J Flint; C H Knight
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

8.  IGF-I and IGF-II genetic variation and breast cancer risk in Chinese women: results from the Shanghai Breast Cancer Study.

Authors:  Sandra L Deming; Zefang Ren; Qiuyin Cai; Xiao-Ou Shu; Wanqing Wen; Ji-Rong Long; Yu-Tang Gao; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-01       Impact factor: 4.254

Review 9.  Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis.

Authors:  S Nandi; R C Guzman; J Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

10.  IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients.

Authors:  Michal Rajski; Rosanna Zanetti-Dällenbach; Brigitte Vogel; Richard Herrmann; Christoph Rochlitz; Martin Buess
Journal:  BMC Med       Date:  2010-01-05       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.